huMannity Medtec

08/20/2026

Since 1985, huMannity MedTec has helped bridge the "valley of death" between promising medical device ideas and patient-ready technologies.

But breakthrough technology needs a breakthrough culture behind it.

In a new article, VP of Human Relations Shawn Lewis shares how huMannity is rebuilding its internal culture to move faster without losing the rigor that regulated medtech demands — from CEO-visible town halls and a rebuilt communications hub, to an 18-month infrastructure overhaul, to a talent strategy that prioritizes "total solution" thinkers over narrow specialists.

As Lewis puts it: "Alignment doesn't happen by accident. It has to be engineered."

Read the full story: https://www.humannitymedtec.org/articles/doing-more-faster-rebuilding-our-culture-from-the-inside-out

07/15/2026

Meet the newest members of the huMannity team 👋

We're excited to welcome our summer interns, who are joining us across a range of roles to support the work of advancing neurotechnology and medical device development. They're bringing fresh energy and new perspectives to our mission.

Welcome aboard! We can't wait to see what you accomplish with us this summer.

06/04/2026

huMannity CEO Dr. Bob Greenberg joined fellow medtech leaders on stage at the 25th Annual Medtech MVP Venture & Partnering Conference in Minneapolis this week for a panel on how AI platforms are shaping the next generation of medical devices.

The discussion covered AI adoption challenges, regulatory considerations, and how companies are integrating AI into their development pipelines — topics that sit at the center of what huMannity does every day.

05/20/2026

SoCalBio is coming to Valencia — and huMannity Medtec is proud to host!

Join us for the longest-running bioscience networking mixer in the Greater LA/OC metro region, right here at our office. Whether you're a founder, researcher, investor, or industry pro, this is the room you want to be in.

📅 Thursday, May 28th
⏰ 4:00 PM – 7:00 PM
📍 huMannity | 25134 Rye Canyon Loop, #200, Valencia, CA 91355

Good conversations. Great connections. The bioscience community at its best. Come be part of it!

https://www.eventbrite.com/e/socalbio-presents-networking-humannity-medtech-tickets-1987343694488

The longest-running bioscience mixer in the Greater Los Angeles/OC Metro Region

05/14/2026

Here’s a blast from the past. Can you guess the technology?

Hint: One was programmed manually with a scalpel screwdriver. The other helped launch a global standard of care.

Okay okay… We’ll just tell you.

The big one on the right is an early pacemaker from 1972 (about the size of a tennis ball). Average battery life? Just 18 months.

The smaller one on the left is a lithium-iodine-powered pacemaker from 1995—a major step forward in both size and capability. This model was one of the first to integrate software-based programming, long-term pacing stability, and greater battery life.

These tiny powerhouses changed the world. Today, over 3 million people are living with pacemakers worldwide. That’s not just progress—it’s lives lived longer, stronger, and more fully.

Alfred Mann played a critical role in early-pacemaker technology, and huMannity's continued that legacy by developing technologies that have had similarly transformative impacts in areas like neuromodulation and targeted drug delivery.

05/04/2026

Forty years ago, Alfred Mann set out to solve one of medicine's most challenging problems: great ideas stalling before they reach patients.

This month, Neurotech Business Report published a profile of huMannity Medtec — tracing that mission from its origins at the Alfred E. Mann Foundation through the spinouts, the setbacks, and the resilience that brought the organization to where it stands today.

More than 600 patents. Over $10 billion in cumulative shareholder value. Technologies that became cochlear implants, insulin pumps, sacral neuromodulators — and programs still in development.

What the piece captures is something central to our model: not every breakthrough succeeds commercially, and that's part of how progress works. What matters is continuing to build the bridges.

Grateful to Jeremy Koff and the Neurotech Business Report team for telling this story.

https://www.neurotechreports.com/images/huMannityMedtecProfile-NeurotechReports.pdf

04/16/2026

When developing next-generation implantable devices, this first question is critical: What exactly are we stimulating?

As John Rivera, our VP of Product Development, explains:

“Not all nerves are the same, and not all conditions can be treated the same way. I’ve heard the phrase ‘stim is stim,’ but that’s incorrect. You have to understand the neuroanatomy and neurophysiology of your target—what it’s composed of and how it behaves.”

Each neural circuit functions differently. A therapy approach that works for chronic pain may not work for movement disorders, and vice versa.

That’s why our process begins with deep research into neural pathways, ensuring that every therapy we develop is tailored to its specific biological target.

04/10/2026

We don’t ask researchers to quit their jobs or lead startups.

If you’re advancing a MedTech concept in neurostimulation or bioelectronic medicine, you can stay focused on your science, while we take the lead on development.

Our in-house team of engineers, scientists, and regulatory experts will guide your idea from concept to clinical readiness.

It’s a model built for researchers who want to see their innovations make an impact without taking on the burdens of commercialization.

Learn more about our unique partnership model: https://www.humannitymedtec.org/pre-development-partners

04/02/2026

Lower burden is better care. When devices reduce manual adjustments, clinic visits, and guesswork, people live their lives with fewer interruptions and less stress.

What this looks like:

Auto-adjustment: sensing and responding in real time for steadier patient relief.

Remote support: secure updates and virtual check-ins that save patient trips.

Usability: clear interfaces and training that reduce patient errors.

We advocate for features that sense, adapt, and support remote care so relief is steadier and days are simpler.

See how we design with burden in mind @ www.humannitymedtec.org/our-work

03/18/2026

In med-tech innovation, closed-loop systems are one of the hottest concepts shaping the future of care.

Devices with closed-loop systems use biofeedback sensing and real-time data to automatically fine-tune therapy, so they can respond to changes in activity, posture, or symptoms, without any manual input from the patient.

As John Rivera, our VP of Product Development, explains:

“Instead of patients having to change their amplitude or stimulation settings… the system should do it for them.”

By removing the burden of constant device adjustments, closed-loop systems give patients more freedom to live their lives—while ensuring their therapy is always optimized.

At huMannity, we’re working toward smarter, more adaptive solutions that put the patient experience at the center of innovation.